MMS Holdings, Inc.
6880 Commerce Boulevard
About MMS Holdings, Inc.
MMS Holdings Inc. is a clinical research organization that focuses on regulatory submission support for the pharmaceutical, biotech and medical device industries. Our strong industry experience and scientific approach to drug development makes us a valuable partner in creating compelling submissions that meet rigorous regulatory standards. Our clients span from top 10 pharma to virtual biotech's, and we support each one with the same standard of excellence. Our core service areas include Regulatory Operations, Data Management, Biostatistics, Clinical Programming, Medical and Regulatory Writing, Pharmacovigilance, Clinical Trial Disclosure and Oncology Data Abstraction. Commitment to quality deliverables sets MMS apart from traditional service providers. MMS is the only CRO to be ISO 9001 certified for all services since inception and we maintain detailed quality metrics for every project. For more information visit: www.mmsholdings.com.
32 articles with MMS Holdings, Inc.
MMS Holdings Executive Michelle Gayari Joins Advisory Board of International Nonprofit That Provides Educational Programs to Children in Hospitals
MMS Holdings announced that its Executive Director of Global Operations Michelle Gayari has joined the advisory board for the international 501 charity Together Educating All Children in Hospitals As its sole board member in the state of Michigan, Gayari will provide leadership, guidance, and fundraising support to help in bringing exciting, hands-on educational programs to children in hospitals.
MMS Holdings Announces Status as a Finalist for Best Contract Research Organization – Specialist Providers in Scrip Awards During 10th Annual Scientific Symposium
CRO renews $250,000 commitment to volunteer program, kicks off leadership program
MMS will share their learnings with peers at the Society for Clinical Data Management (SCDM) annual meeting in Baltimore, Md.
MMS Holdings Named Honorable Mention in Prestigious PR Daily Corporate Social Responsibility Awards for #OneMMS Volunteer Initiative
MMS Holdings – an award-winning, data-focused CRO – was recently announced as an honorable mention recipient of PR Daily’s Corporate Social Responsibility Awards in the Engagement & Communications category for its #OneMMS volunteer campaign.
MMS Holdings and Sage IT Celebrate 10-Year Relationship with Deep Focus on Intelligent Automation and Bot Development
Leveraging artificial intelligence (AI) and (NLP) for document development and authoring
The former Gates Foundation executive is helping redefine the CRO experience
Detroit-Area Life Sciences Firm Pledges More Than $250,000 in Employee Hours to Local Volunteer Initiatives
MMS Holdings, Inc. (MMS) – award-winning, data-focused CRO – announced today its renewed dedication to the local communities surrounding Detroit and Ann Arbor by allocating a substantial amount of colleague time to volunteer initiatives over the next year.
MMS Supported Clinical Data Aspects in Gemphire Therapeutics Meeting its Primary Endpoint in Gemcabene Study
MMS Holdings Inc. announced its integrated support for Gemphire Therapeutics Inc
MMS Holdings, Inc. (MMS) - a leading global clinical research organization - announced today that Lisa James has joined as Director, Business Operations and Client Relations.
Is among the lowest attrition rates in the pharmaceutical industry regionally.
MMS Partners with University of Findlay to Provide Medical Writing and Clinical Trial Disclosure Courses
The MMS Courses offered provide the necessary technical writing skills needed to be a successful medical writer preparing documents to support drug development and in preparing clinical trial disclosures.
MMS announced today that it was selected by Paratek Pharma to support the development of its U.S. NDAs for omadacycline.
MMS Holdings, Inc. And Oncology Trials Insights Form Strategic Partnership To Deliver Comprehensive Oncology Support Services
DATATRAK International, Inc. Signs Specialty CRO, MMS Holdings, Inc., as DATATRAK Connect™ Partner